China conditionally approves Linde/Praxair merger
China’s competition authority will allow Linde’s proposed $83 billion merger with Praxair based on structural and behavioural remedies, leaving the US and Korea as the last major jurisdictions yet to clear the deal.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now